Aram Bidikian

10PUBLICATIONS
62CO-AUTHORS
Haematological tumoursNanotoxicology, health and safetyAudiologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

|Jan 09, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants.

Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari

|Dec 17, 2024
Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them.

Aram Bidikian, Jan Philipp Bewersdorf, Tariq Kewan

|Jul 24, 2023
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era.

Fadi G Haddad, Koji Sasaki, Aram Bidikian

|May 03, 2023
Reply to "Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!"

Fadi G Haddad, Aram Bidikian, Ghayas C Issa

|Apr 13, 2023
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience.

Adriana Trabal, Amber Gibson, Jiasen He

Pageof 2

Frequent Collaborators

8 joint publications

Ghayas C Issa

6 joint publications

Nicholas J Short

6 joint publications

Koji Sasaki

5 joint publications

Elias Jabbour